Moderna has delayed its break-even goal by two years, pushing it to 2028, due to slower regulatory processes for key products like flu and ...

The final list of 29 – selected from an initial list of 115 female leaders from corporate India – are the names to keenly watch for in the ...

This year, as we continue the journey towards a decade, Startup India remains firmly in focus, in keeping with the country’s standing as th...

After facing a phase of uncertainty that the aggressive entry of Patanjali brought to oral care markets, established players in the space h...

Drugmaker Cipla said it is scaling up offerings and expanding access to medicines, inhaler devices, diagnostics, as it aspires to become th...

Companies had flocked to rural centres when demand was dwindling in urban areas in the initial phases of the virus outbreak. Now, with incr...

The 133.77 million shares were offloaded on average for 1,905 rupees, according to a statement from GlaxoSmithKline.

Here is a look at the key stocks trending in news this morning.

“The parent company feels confident that we are here to deliver.”

When a German trader asked Reddy if he could match boots’ quality, Reddy retorted he could, by adding some impurity.

GlaxoSmithKline PLC, the world's second largest drug maker by revenue, reported Thursday that its fourth-quarter profit soared by 66 percen...

The world's No 2 drugmaker by revenue also will switch from having dual US headquarters to just North Carolina. Shrinking job mkt: The next...